WO2001013927A3 - Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof - Google Patents
Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof Download PDFInfo
- Publication number
- WO2001013927A3 WO2001013927A3 PCT/US2000/023300 US0023300W WO0113927A3 WO 2001013927 A3 WO2001013927 A3 WO 2001013927A3 US 0023300 W US0023300 W US 0023300W WO 0113927 A3 WO0113927 A3 WO 0113927A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- spores
- bacillus coagulans
- fungi
- bacterium
- yeast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Pest Control & Pesticides (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00961363A EP1212069B1 (en) | 1999-08-26 | 2000-08-25 | Improved topical compositions containing extracellular products of probiotic bacteria and uses thereof |
AU73324/00A AU783418B2 (en) | 1999-08-26 | 2000-08-25 | Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
JP2001518064A JP2003507428A (en) | 1999-08-26 | 2000-08-25 | Improved topical compositions comprising commensal bacteria, spores and extracellular products, and uses thereof |
AT00961363T ATE308988T1 (en) | 1999-08-26 | 2000-08-25 | IMPROVED TOPICAL COMPOSITIONS CONTAINING EXTRACELLULAR PROBIOTIC BACTERIA PRODUCTS AND USES THEREOF |
DE60023919T DE60023919T2 (en) | 1999-08-26 | 2000-08-25 | IMPROVED TOPICAL COMPOSITIONS WITH EXTRACELLULAR PRODUCTS OF PROBIOTIC BACTERIA AND USES THEREOF |
CA2382840A CA2382840C (en) | 1999-08-26 | 2000-08-25 | Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/383,975 | 1999-08-26 | ||
US09/383,975 US6645506B1 (en) | 1997-04-18 | 1999-08-26 | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001013927A2 WO2001013927A2 (en) | 2001-03-01 |
WO2001013927A3 true WO2001013927A3 (en) | 2001-08-30 |
WO2001013927A9 WO2001013927A9 (en) | 2002-07-11 |
Family
ID=23515538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/023300 WO2001013927A2 (en) | 1999-08-26 | 2000-08-25 | Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (6) | US6645506B1 (en) |
EP (2) | EP1212069B1 (en) |
JP (1) | JP2003507428A (en) |
AT (1) | ATE308988T1 (en) |
AU (1) | AU783418B2 (en) |
CA (1) | CA2382840C (en) |
DE (1) | DE60023919T2 (en) |
ES (1) | ES2256036T3 (en) |
WO (1) | WO2001013927A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102105132B (en) * | 2008-07-29 | 2014-12-10 | 欧莱雅 | Cosmetic use of microorganisms for the treatment of oily skin |
CN103468684B (en) * | 2012-01-05 | 2016-04-06 | 集美大学 | Aeromonas hydrophila is fit and screening method and application |
Families Citing this family (145)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2020959C1 (en) * | 1991-10-21 | 1994-10-15 | Игорь Дмитриевич Поляков | Vaccine for prevention and treatment of dermatophytoses in animals |
US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
JP4678896B2 (en) * | 1997-04-18 | 2011-04-27 | ガネデン バイオテック,インコーポレイテッド | Topical use of symbiotic Bacillus spores to prevent or control microbial infection |
US6716435B1 (en) * | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
WO2001013956A2 (en) * | 1999-08-26 | 2001-03-01 | Ganeden Biotech, Inc. | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
AU783905B2 (en) * | 1999-08-26 | 2005-12-22 | Ganeden Biotech, Inc. | Use of emu oil carrier for antifungal, antibacterial, and antiviral medications |
US6849256B1 (en) | 1999-11-08 | 2005-02-01 | Ganeden Biotech Incorporated | Inhibition of pathogens by probiotic bacteria |
EP1110555A1 (en) * | 1999-12-22 | 2001-06-27 | Societe Des Produits Nestle S.A. | Antiadhesive agent for the pathogen flora of the skin |
US7547527B2 (en) * | 2000-10-06 | 2009-06-16 | Markus Baur | Use of probiotic lactic acid bacteria for balancing the skin's immune system |
KR100743404B1 (en) | 2000-12-21 | 2007-07-30 | 넥타르 테라퓨틱스 | Pulmonary delivery of polyene antifungal agents |
US20070190591A1 (en) * | 2001-05-02 | 2007-08-16 | Grech Nigel M | Microbial compositions and methods of use in water |
AU2002348340B2 (en) * | 2001-11-05 | 2008-07-03 | Ganeden Biotech, Inc. | Probiotic compositions |
US6878373B2 (en) * | 2001-12-03 | 2005-04-12 | Micropure Technologies, Inc. | Probiotic composition containing Bacillus cereus RRRL B-30535 |
US7182943B2 (en) * | 2002-05-15 | 2007-02-27 | UNIVERSITé LAVAL | Method and system for modulation of microbial cell characteristics |
US7595065B2 (en) * | 2002-06-25 | 2009-09-29 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils |
CN1723011A (en) * | 2002-06-25 | 2006-01-18 | Wm·雷格利Jr·公司 | Breath freshening and oral cleansing product with magnolia bark extract |
US7632525B2 (en) * | 2002-06-25 | 2009-12-15 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
WO2004006957A1 (en) * | 2002-07-15 | 2004-01-22 | Alcon, Inc. | Pharmaceutical compositions for otic use |
EP1596872B1 (en) * | 2003-01-24 | 2011-06-22 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
US7052715B2 (en) * | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
US20050019379A1 (en) * | 2003-07-22 | 2005-01-27 | Kimberly-Clark Worldwide, Inc. | Wipe and methods for improving skin health |
US8192733B2 (en) | 2003-08-29 | 2012-06-05 | Cobb & Associates | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
US7731976B2 (en) * | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
US7759105B2 (en) * | 2003-08-29 | 2010-07-20 | Cobb & Company, Llp | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
US7749509B2 (en) * | 2003-08-29 | 2010-07-06 | Cobb And Company, Llp | Treatment of autism using probiotic composition |
EP1506781B1 (en) * | 2003-11-03 | 2005-02-23 | Peter-Hansen Volkmann | Vaginal care composition |
BRPI0418589A (en) | 2003-12-08 | 2008-01-29 | Bentley Pharmaceuticals Inc | pharmaceutical compositions and methods for insulin treatment |
US20050226947A1 (en) * | 2004-02-04 | 2005-10-13 | Dale Kern | Agents for sequestering serum aging factors and uses therefore |
US7510734B2 (en) * | 2004-03-04 | 2009-03-31 | E-L Management Corporation | Skin treatment method with Lactobacillus extract |
WO2005086821A2 (en) * | 2004-03-10 | 2005-09-22 | Avia Candle Company Inc | Antimicrobial wax composition for wax therapy |
WO2006113925A2 (en) * | 2005-04-20 | 2006-10-26 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
US20050244402A1 (en) * | 2004-04-30 | 2005-11-03 | Villanueva Julie M | Absorption of pain-causing agents |
US7854927B2 (en) * | 2004-05-11 | 2010-12-21 | Ganeden Biotech, Inc. | Methods and compositions for the dietary management of autoimmune disorders |
US7446904B2 (en) * | 2004-05-28 | 2008-11-04 | Infoprint Solutions Company, Llc | Methods and apparatus for generating dither mask through interpolation between preferred patterns |
US7252846B2 (en) | 2004-05-28 | 2007-08-07 | Raied Dinno | Topical composition and method for the treatment and prophylaxis of dermal irritations |
FR2872047B1 (en) * | 2004-06-23 | 2007-06-15 | Oreal | COMPOSITION FOR SENSITIVE SKINS COMBINING MINERAL AND PROBIOTIC CATION (S) |
JP2008503563A (en) * | 2004-06-23 | 2008-02-07 | ロレアル | Methods and compositions useful for the prevention and / or treatment of sensitive and / or dry skin |
US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
AU2005291098B2 (en) * | 2004-10-04 | 2011-11-24 | L'oreal | Cosmetic and/or dermatological composition for sensitive skins |
US8092793B2 (en) * | 2004-12-15 | 2012-01-10 | Qingdao East Sea Pharmaceuticals, Ltd. | Treating inflammatory bowel disease with live bacteria |
WO2006076780A1 (en) * | 2004-12-17 | 2006-07-27 | Gielen Cornelis | Use of non-pathogenic bacterial strains in cleaning and milking an animal |
US20060147507A1 (en) * | 2005-01-04 | 2006-07-06 | Marie Cammarata | Hot flash treatment system |
DE502005010458D1 (en) * | 2005-04-28 | 2010-12-09 | Osipova Irina Grigorievna | IRILIS BIOPRÄPARATION BASED ON BACILLUS BACTERUS BARS BACILLUS SUBTILIS AND BACILLUS LICHENIFORMIS CONTAINING THEREIN |
DE102005020457A1 (en) * | 2005-04-29 | 2006-11-02 | Westfaliasurge Gmbh | Use of non-pathogenic sporulating bacteria for inhibiting the growth of infectious germs on the udder and/or teat of a lactating mammal |
FR2889057B1 (en) * | 2005-08-01 | 2008-07-18 | Oreal | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF SENSITIVE OR DRY SKINS |
WO2007038466A2 (en) * | 2005-09-27 | 2007-04-05 | Cobb & Company | Treatment of bipolar disorder utilizing anti-fungal compositions |
US20080220103A1 (en) * | 2005-10-24 | 2008-09-11 | Jay Birnbaum | Method for treating/controlling/killing fungi and bacteria on living animals |
EP1945033A1 (en) * | 2005-10-24 | 2008-07-23 | Staval Pharma, Ltd. | Method for treating/controlling/killing fungi and bacteria |
US20090324547A1 (en) * | 2006-01-04 | 2009-12-31 | Wikstroem Maude | Probiotic Oral Health Promoting Product |
US20070238145A1 (en) * | 2006-02-21 | 2007-10-11 | Cote Mindy A | Phenotypic engineering of spores |
CN101095698B (en) * | 2006-06-26 | 2010-12-01 | 青岛东海药业有限公司 | Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease |
US20080031979A1 (en) * | 2006-08-04 | 2008-02-07 | Claude Saliou | Use of extracts for the treatment of viral disorders |
CA2660645C (en) | 2006-08-11 | 2016-04-05 | Novozymes Biologicals, Inc. | Bacillus cultures for use in washing, cleaning, stain removal, or degrading waste materials |
US7858126B2 (en) | 2006-08-31 | 2010-12-28 | Trinity Laboratories Inc. | Derivatives of sandalwood oil and santalols for treating cold sores and herpes |
US20080075680A1 (en) * | 2006-09-27 | 2008-03-27 | Chen Jonathan Y | Culture of microorganisms endogenous to plants and products thereof |
US20080107699A1 (en) * | 2006-10-25 | 2008-05-08 | Mark Spigelman | Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
CN101134052A (en) * | 2006-11-17 | 2008-03-05 | 青岛东海药业有限公司 | Application of clostridium butyricum, condensate bacillus and bifidobacteria in the preparation of medicament for preventing and treating mouth ulcer |
CA2671615A1 (en) * | 2006-12-04 | 2008-06-12 | Smithkline Beecham Corporation | Topical pharmaceutical composition |
FR2914189A1 (en) * | 2007-03-26 | 2008-10-03 | Oreal | USE OF A LIPOPOLYSACCHARIDE FRACTION OF VITREOSCILLA FILIFORMIS AS AGENT STIMULATING THE SYNTHESIS OF ANTIMICROBIAL PEPTIDES OF THE SKIN. |
KR101527829B1 (en) | 2007-04-19 | 2015-06-12 | 마리 케이 인코포레이티드 | Magnolia extract containing compositions |
FR2915388B1 (en) | 2007-04-27 | 2010-12-24 | Oreal | COSMETIC WATER SOLUBLE FILM |
TW200904340A (en) | 2007-05-11 | 2009-02-01 | Mannatech Inc | Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
FR2919501B1 (en) * | 2007-08-02 | 2010-12-31 | Oreal | USE OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR THE PREVENTION AND / OR TREATMENT OF RELEASED SKINS |
LT2211626T (en) | 2007-08-29 | 2019-11-11 | Ganeden Biotech Inc | Baked goods |
FR2920305B1 (en) | 2007-09-04 | 2010-07-30 | Oreal | USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS. |
ES2461791T3 (en) * | 2007-09-04 | 2014-05-21 | L'oréal | Use of a combination of hesperidin and a microorganism to act on the skin's barrier function |
FR2920304B1 (en) | 2007-09-04 | 2010-06-25 | Oreal | COSMETIC USE OF LYSAT BIFIDOBACTERIUM SPECIES FOR THE TREATMENT OF DROUGHT. |
ES2700855T3 (en) * | 2007-10-16 | 2019-02-19 | Ganeden Biotech Inc | Drinkable compositions |
US20090107007A1 (en) * | 2007-10-31 | 2009-04-30 | Mitchellace, Inc. | Insole with included aloe extract |
US9314524B2 (en) * | 2007-12-31 | 2016-04-19 | Calla Therapeutics Llc | Topical formulations of Flucytosine |
WO2009099562A2 (en) * | 2008-01-30 | 2009-08-13 | Ganeden Biotech, Inc. | Compositions and methods for cleaning surfaces |
US20090246152A1 (en) * | 2008-03-28 | 2009-10-01 | Nu Skin International, Inc. | Naractin compositions for the inhibition of reactive oxygen species |
US20090246153A1 (en) * | 2008-03-28 | 2009-10-01 | Nu Skin International, Inc. | Cosmetic compositions for the inhibition of reactive oxygen species |
US7788209B2 (en) * | 2008-05-05 | 2010-08-31 | United Technologies Corporation | Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning |
KR101764592B1 (en) * | 2008-09-24 | 2017-08-23 | 레실럭스 | Incorporation of thermo-resistant and/or pressure-resistant organisms in materials |
WO2010045367A1 (en) * | 2008-10-14 | 2010-04-22 | Dr Pepper/Seven Up, Inc. | Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same |
US9622502B2 (en) | 2008-10-16 | 2017-04-18 | Ganeden Biotech, Inc. | Probiotic Bacillus pasta compositions |
FR2942719B1 (en) | 2009-03-04 | 2011-08-19 | Oreal | USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION |
ES2639364T3 (en) | 2009-04-29 | 2017-10-26 | Ganeden Biotech, Inc. | Bacterial cell membrane formulation |
WO2011003062A2 (en) * | 2009-07-03 | 2011-01-06 | James Madison University | Probiotic compositions and processes thereof |
FR2954140A1 (en) * | 2009-12-17 | 2011-06-24 | Oreal | COSMETIC OR DERMATOLOGICAL COMPOSITIONS BASED ON BACTERIOCINS AND PREBIOTICS |
EP2338331A1 (en) * | 2009-12-22 | 2011-06-29 | Research Center Pharmaceutical Engineering GmbH | Methods and compositions for biologically controlling microbial growth on clean room equipment |
US20110229446A1 (en) * | 2010-03-02 | 2011-09-22 | Roman Stephen B | Method and composition to relieve sexual discomfort and improve vaginal health |
CN103037877A (en) * | 2010-03-12 | 2013-04-10 | 可尔必思株式会社 | Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
WO2011130487A1 (en) | 2010-04-14 | 2011-10-20 | Ganeden Biotech, Inc. | Probiotic confection and lipid compositions |
JP2013529642A (en) * | 2010-06-24 | 2013-07-22 | ノボザイムス バイオロジカルズ,インコーポレイティド | Methods and compositions for reducing body odor |
WO2012027214A1 (en) * | 2010-08-25 | 2012-03-01 | Tate & Lyle Ingredients Americas Llc | Synbiotic product |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
FR2968991B1 (en) * | 2010-12-17 | 2013-01-11 | Oreal | "USE OF STABLE MICROBIAL POPULATION TO PREVENT AND / OR TREAT THE DISORDERS OF FRAGILIZED OR DAMAGED LIP" |
EP2654432B1 (en) * | 2010-12-22 | 2017-02-08 | Roombiotic GmbH | Volatile organic compounds from bacterial antagonists for controlling microbial growth |
EP2675891B1 (en) | 2011-02-15 | 2018-06-20 | Novozymes Biologicals, Inc. | Mitigation of odor in cleaning machines and cleaning processes |
WO2012135499A1 (en) | 2011-03-31 | 2012-10-04 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
US20120255334A1 (en) * | 2011-04-08 | 2012-10-11 | Stephen Gans | Soluble organic fertilizer |
US20120308490A1 (en) * | 2011-06-06 | 2012-12-06 | Abr Consulting S.R.L. | Method of obtaining a preparation of biological origin for oral hygiene to prevent the onset of tooth decay |
US9004374B1 (en) * | 2011-07-20 | 2015-04-14 | Stephen Gans | Irrigation method using thixotropic materials |
EP2838524B1 (en) * | 2012-04-20 | 2023-07-05 | Hennepin Life Sciences | Compositions for topical treatment of microbial infections |
GB201312713D0 (en) | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
US9557331B2 (en) | 2013-08-23 | 2017-01-31 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
US9390312B2 (en) | 2013-08-23 | 2016-07-12 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
US9805171B2 (en) | 2013-08-23 | 2017-10-31 | Elwha Llc | Modifying a cosmetic product based on a microbe profile |
US9456777B2 (en) | 2013-08-23 | 2016-10-04 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
US9811641B2 (en) | 2013-08-23 | 2017-11-07 | Elwha Llc | Modifying a cosmetic product based on a microbe profile |
US10010704B2 (en) | 2013-08-23 | 2018-07-03 | Elwha Llc | Systems, methods, and devices for delivering treatment to a skin surface |
US10152529B2 (en) | 2013-08-23 | 2018-12-11 | Elwha Llc | Systems and methods for generating a treatment map |
US8883747B1 (en) | 2013-10-09 | 2014-11-11 | Craig W. Carver | Topical antifungal compositions and methods of use thereof |
US9596861B2 (en) | 2013-12-24 | 2017-03-21 | Sami Labs Limited | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
BR112016022455B1 (en) * | 2014-03-31 | 2021-03-16 | Lubrizol Advanced Materials, Inc | use of a supernatant from cultures of a strain of bacillus pumilus species, unnatural cosmetic or dermopharmaceutical composition; skin, stimulate collagen synthesis and / or hyaluronic acid synthesis, treatment of skin tightening and / or prevention of loss of skin firmness |
CN104946550A (en) * | 2014-05-12 | 2015-09-30 | 山东黎昊源生物工程有限公司 | Leaf-protection biological strain repair agent |
MX2016014901A (en) | 2014-05-13 | 2017-06-29 | Microbial Discovery Group Llc | Direct-fed microbials and methods of their use. |
US10004768B2 (en) * | 2014-09-25 | 2018-06-26 | Iryohojin Kiyokai | Treatment of atopic dermatitis and infectious dermatitis with biological spa therapy |
EA027597B1 (en) * | 2014-10-09 | 2017-08-31 | Александр Владимирович Синица | Composition with probiotic, hepatoprotective, antioxidant and immune modulating activity |
WO2016183535A1 (en) | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
CN105132307B (en) * | 2015-07-22 | 2017-12-12 | 江南大学 | It is a kind of applied to the composite bacillus microbial water-purifying agent of ornamental fish and its application |
DE102015010874B4 (en) * | 2015-08-25 | 2017-06-14 | Fritz Stephan Gmbh Medizintechnik | Suit for a newborn, especially a premature baby |
CN108347947A (en) * | 2015-10-30 | 2018-07-31 | 以Z生物科学公司名义营业的Z益生菌公司 | Probiotic composition and application thereof |
WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
WO2017173241A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
JP2019515886A (en) * | 2016-03-31 | 2019-06-13 | ゴジョ・インダストリーズ・インコーポレイテッド | Topical composition for reducing pathogen binding |
EP3436156A1 (en) | 2016-03-31 | 2019-02-06 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
AU2017253935B2 (en) * | 2016-04-19 | 2021-07-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
AR108659A1 (en) * | 2016-06-03 | 2018-09-12 | Valent Biosciences Llc | NON-WATERY, NON-OILY COMPOSITIONS WITH BACILLUS AMYLOLIQUEFACIENS |
CA3036773A1 (en) * | 2016-09-14 | 2018-03-22 | Grace Breeding Ltd. | Compositions comprising a non-pathogenic bacteria and methods for protecting plant and animal hosts from fungal, bacterial and viral diseases |
BE1024189B1 (en) * | 2016-10-28 | 2017-12-05 | Yun NV | SPRAYER WITH BACTERIAL SPECIES |
AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
IT201700005552A1 (en) * | 2017-01-19 | 2018-07-19 | Copma S C A R L | EUTROFIZZANTE PRODUCT FOR COSMETIC USE |
AU2018282067B2 (en) * | 2017-06-06 | 2022-01-27 | Sami Labs Limited | Skin care applications of extracellular metabolites from Bacillus coagulans |
US11123382B2 (en) * | 2017-06-06 | 2021-09-21 | Sami Labs Limited | Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans |
AU2018282252B2 (en) * | 2017-06-06 | 2021-07-15 | Sami Labs Limited | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 |
WO2019018944A1 (en) * | 2017-07-28 | 2019-01-31 | Davincia Inc. | Topical composition for rejuvenating and/or repairing skin, methods, uses and kits thereof |
EP3678636A4 (en) * | 2017-09-07 | 2021-06-09 | Technion Research & Development Foundation Limited | Topical kits and compositions and use thereof |
US20200338139A1 (en) * | 2017-12-04 | 2020-10-29 | Sami Labs Limited | Compositions for microbial anti-adhesion |
WO2019113096A1 (en) | 2017-12-05 | 2019-06-13 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
WO2019212379A1 (en) * | 2018-05-04 | 2019-11-07 | Farber Boris Slavinovich | Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect |
FR3085687B1 (en) * | 2018-09-07 | 2021-05-14 | Nolivade | COMPOSITION AND PRESERVATION PROCESS |
WO2020072642A1 (en) * | 2018-10-02 | 2020-04-09 | Nutech Ventures | Novel gras probiotic bacterial strain to inhibit acidosis and liver abscesses in cattle |
AU2019393877A1 (en) * | 2018-12-05 | 2021-06-17 | Seres Therapeutics, Inc. | Compositions for stabilizing bacteria and uses thereof |
WO2020132098A1 (en) * | 2018-12-19 | 2020-06-25 | Healthy Cow Corporation | Ready-to-use probiotic compositions and uses thereof |
CN109464313A (en) * | 2019-01-22 | 2019-03-15 | 杭州百芮生物科技有限公司 | A kind of preparation method and biology cellulose diaphragm of external preparation for skin Essence |
WO2020191173A1 (en) * | 2019-03-19 | 2020-09-24 | Microbial Discovery Group, Llc | Microbial strains for virus inhibition |
CN113699085B (en) * | 2021-11-01 | 2022-02-08 | 渤海水产科技(滨州)有限公司 | Antagonistic bacterium ED5 and application thereof |
CN114767936B (en) * | 2022-05-10 | 2023-04-18 | 武汉理工大学 | Preparation method of composite lactobacillus casei bracket material for repairing skin injury |
CN115074286B (en) * | 2022-07-01 | 2023-06-06 | 安徽农业大学 | Bacillus pumilus for antagonizing tinea pedis pathogenic fungi and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997002846A1 (en) * | 1995-07-13 | 1997-01-30 | SCA Mölnlycke AB | Inhibiting the growth of bacteria in absorbent articles by adding other bacteria |
WO1998047374A1 (en) * | 1997-04-18 | 1998-10-29 | Ganeden Biotech, Inc. | Topical use of probiotic bacillus spores to prevent or control microbial infections |
WO2000007606A2 (en) * | 1998-08-07 | 2000-02-17 | Ganeden Biotech, Inc. | Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
WO2000010582A2 (en) * | 1998-08-24 | 2000-03-02 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
WO2000061201A1 (en) * | 1999-04-14 | 2000-10-19 | Ganeden Biotech, Inc. | Methods for inhibiting microbial infections associated with sanitary products |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7401939A (en) * | 1974-02-13 | 1975-08-15 | Philips Nv | LOAD-CONNECTED DEVICE. |
US4062943A (en) * | 1974-11-20 | 1977-12-13 | Board Of Supervisors Louisiana State University A & M | Antibiotic produced from the microorganism (Pseudomonas lindbergii), its preparation and method of use |
US4323651A (en) * | 1974-12-04 | 1982-04-06 | R. J. Reynolds Tobacco Company | Thermostable lactase derived from bacillus |
JPS52102419A (en) * | 1976-02-23 | 1977-08-27 | Seikenkai | Lactic acid producing bacillus preparation |
US4110477A (en) | 1977-05-13 | 1978-08-29 | Kabushiki Kaisha Naruse Fermentation Laboratory | Method for producing natto containing lactic acid bacteria |
JPS55113718A (en) * | 1979-02-27 | 1980-09-02 | Yakult Honsha Co Ltd | Antitumor agent |
IE59628B1 (en) * | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
JPH01199575A (en) * | 1988-02-04 | 1989-08-10 | Rikagaku Kenkyusho | Novel cyclomaltodextrin-glucano transferase and production thereof |
IT1227154B (en) | 1988-08-05 | 1991-03-19 | A Tosi Farmaceutici S R L Nova | PHARMACEUTICAL COMPOSITIONS FOR GYNECOLOGICAL USE BASED ON LATTOBACILLI |
AT391323B (en) | 1989-03-10 | 1990-09-25 | Jungbunzlauer Ag | MICROORGANISM OF THE SPECIES BACILLUS COAGULANS AND A METHOD FOR THE PRODUCTION OF OPTICALLY PURE L (+) - LACTIC ACID |
US5371011A (en) * | 1989-07-10 | 1994-12-06 | Zeneca Corp. | Mold control in forage |
FR2656314B1 (en) * | 1989-12-22 | 1992-04-17 | Bp Chemicals Snc | ZIRCONIUM CATALYST SUPPORTED ON MAGNESIUM CHLORIDE, PROCESS FOR THE PREPARATION AND USE OF THE CATALYST IN OLEFIN POLYMERIZATION. |
DE4001611C1 (en) * | 1990-01-20 | 1991-02-28 | Skw Trostberg Ag, 8223 Trostberg, De | |
US5200336A (en) * | 1990-07-02 | 1993-04-06 | New England Biolabs, Inc. | Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same |
JP3172177B2 (en) * | 1990-11-14 | 2001-06-04 | イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ. リミテッド | Anti-flame mixtures derived from emu oil |
IT1262927B (en) | 1992-01-14 | 1996-07-22 | Consiglio Nazionale Ricerche | EXTENDING BACTERIA AND THEIR USE AS PROBIOTICS |
FI92498C (en) * | 1992-06-10 | 1994-11-25 | Valio Meijerien | New microorganism strain, bacterial preparations containing it and their use for controlling yeast and mold |
JPH06166623A (en) * | 1992-09-25 | 1994-06-14 | Toyama Chem Co Ltd | Antimicrobial composition |
WO1994011492A1 (en) | 1992-11-12 | 1994-05-26 | Chr. Hansen's Laboratory, Inc. | Method of favorably modifying poultry intestinal microflora |
US6103246A (en) * | 1993-06-03 | 2000-08-15 | Tisdale; Carrie J. | Creams and lotions containing emu oil |
US5540920A (en) * | 1994-11-22 | 1996-07-30 | Olin Corporation | Synergistic biocide composition containing pyrithione plus an additive |
US5472713A (en) * | 1994-11-23 | 1995-12-05 | Elf Resources, Inc. | Therapeutic uses of emu oil |
US5698227A (en) * | 1996-07-23 | 1997-12-16 | Rivlin; Daniel | Compositions comprising lidocaine and emu oil and methods of use thereof |
US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
US7374753B1 (en) * | 1997-06-03 | 2008-05-20 | Ganeden Biotech, Inc. | Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS |
AU750136B2 (en) * | 1997-06-03 | 2002-07-11 | Ganeden Biotech, Inc. | Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS |
US6261577B1 (en) * | 1997-07-16 | 2001-07-17 | Symbollon Corporation | Non-staining topical iodine composition and method |
US6312703B1 (en) * | 1998-02-06 | 2001-11-06 | Lecigel, Llc | Compressed lecithin preparations |
US6811786B1 (en) * | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
WO2001013956A2 (en) * | 1999-08-26 | 2001-03-01 | Ganeden Biotech, Inc. | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
US6849256B1 (en) * | 1999-11-08 | 2005-02-01 | Ganeden Biotech Incorporated | Inhibition of pathogens by probiotic bacteria |
US6416772B1 (en) * | 2001-01-12 | 2002-07-09 | H. Wayne Van Engelen | Topical dermal anaesthetic |
AU2002348340B2 (en) * | 2001-11-05 | 2008-07-03 | Ganeden Biotech, Inc. | Probiotic compositions |
US20030143262A1 (en) * | 2001-12-13 | 2003-07-31 | Brusk Ulla Forsgren | Hygiene tissue |
US6579543B1 (en) * | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
-
1999
- 1999-08-26 US US09/383,975 patent/US6645506B1/en not_active Expired - Lifetime
-
2000
- 2000-07-20 US US09/620,622 patent/US6723326B1/en not_active Expired - Lifetime
- 2000-08-25 AU AU73324/00A patent/AU783418B2/en not_active Expired
- 2000-08-25 CA CA2382840A patent/CA2382840C/en not_active Expired - Lifetime
- 2000-08-25 AT AT00961363T patent/ATE308988T1/en active
- 2000-08-25 EP EP00961363A patent/EP1212069B1/en not_active Expired - Lifetime
- 2000-08-25 JP JP2001518064A patent/JP2003507428A/en active Pending
- 2000-08-25 DE DE60023919T patent/DE60023919T2/en not_active Expired - Lifetime
- 2000-08-25 ES ES00961363T patent/ES2256036T3/en not_active Expired - Lifetime
- 2000-08-25 EP EP05024273A patent/EP1632239A1/en not_active Withdrawn
- 2000-08-25 WO PCT/US2000/023300 patent/WO2001013927A2/en active IP Right Grant
-
2002
- 2002-06-28 US US10/184,665 patent/US6905692B2/en not_active Expired - Lifetime
-
2005
- 2005-06-14 US US11/152,894 patent/US7541042B2/en not_active Expired - Lifetime
-
2007
- 2007-10-12 US US11/974,427 patent/US7544363B2/en not_active Expired - Lifetime
-
2009
- 2009-06-05 US US12/479,064 patent/US7807185B2/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997002846A1 (en) * | 1995-07-13 | 1997-01-30 | SCA Mölnlycke AB | Inhibiting the growth of bacteria in absorbent articles by adding other bacteria |
WO1998047374A1 (en) * | 1997-04-18 | 1998-10-29 | Ganeden Biotech, Inc. | Topical use of probiotic bacillus spores to prevent or control microbial infections |
WO2000007606A2 (en) * | 1998-08-07 | 2000-02-17 | Ganeden Biotech, Inc. | Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
WO2000010582A2 (en) * | 1998-08-24 | 2000-03-02 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
WO2000061201A1 (en) * | 1999-04-14 | 2000-10-19 | Ganeden Biotech, Inc. | Methods for inhibiting microbial infections associated with sanitary products |
Non-Patent Citations (2)
Title |
---|
HODGES C F ET AL: "Potential biocontrol of Sclerotina homeocarpa and Bipolaris sorokiniana on the phylloplane of Poa pratensis with strains of Pseudomonas sp.", PLANT PATHOLOGY, vol. 43, no. 3, 1994, pages 500 - 506, XP000982028 * |
ZEMTSOV ET AL: "Moisturizing and cosmetic properties of emu oil: A pilot double blind study", AUSTRALASIAN JOURNAL OF DERMATOLOGY, vol. 37, no. 3, August 1996 (1996-08-01), pages 159 - 162, XP000982121 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102105132B (en) * | 2008-07-29 | 2014-12-10 | 欧莱雅 | Cosmetic use of microorganisms for the treatment of oily skin |
CN103468684B (en) * | 2012-01-05 | 2016-04-06 | 集美大学 | Aeromonas hydrophila is fit and screening method and application |
Also Published As
Publication number | Publication date |
---|---|
US7544363B2 (en) | 2009-06-09 |
WO2001013927A9 (en) | 2002-07-11 |
DE60023919T2 (en) | 2006-08-10 |
US20030003107A1 (en) | 2003-01-02 |
CA2382840C (en) | 2011-05-24 |
US20090238907A1 (en) | 2009-09-24 |
EP1212069A2 (en) | 2002-06-12 |
ATE308988T1 (en) | 2005-11-15 |
DE60023919D1 (en) | 2005-12-15 |
US6905692B2 (en) | 2005-06-14 |
US20050271758A1 (en) | 2005-12-08 |
US20080089963A1 (en) | 2008-04-17 |
ES2256036T3 (en) | 2006-07-16 |
US7807185B2 (en) | 2010-10-05 |
US6645506B1 (en) | 2003-11-11 |
CA2382840A1 (en) | 2001-03-01 |
JP2003507428A (en) | 2003-02-25 |
US6723326B1 (en) | 2004-04-20 |
US7541042B2 (en) | 2009-06-02 |
WO2001013927A2 (en) | 2001-03-01 |
EP1212069B1 (en) | 2005-11-09 |
AU783418B2 (en) | 2005-10-27 |
EP1632239A1 (en) | 2006-03-08 |
AU7332400A (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001013927A3 (en) | Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof | |
Castoria et al. | β-1, 3-glucanase activity of two saprophytic yeasts and possible mode of action as biocontrol agents against postharvest diseases | |
WO2001013956A3 (en) | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications | |
WO2001058276A3 (en) | Use of acid-stable proteases in animal feed | |
WO2003005963A3 (en) | Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating foods therewith | |
ATE496989T1 (en) | PROBIOTIC STRAINS OF LACTOBACILLUS SALIVARIUS AND ANTIMICROBIAL AGENTS PRODUCED THEREFROM | |
YU69401A (en) | A strain of bacillus pumilus for controlling plant diseases | |
NZ335521A (en) | Bacillus thuringiensis strain AQ52 for controlling antimicrobial activity against fungi and bacteria | |
DE60216613D1 (en) | BIO-TERMINAL COMPOSITION CONTAINING BACTERIA OF SPECIES B.SUBTILIS OR B. LENTIMORBUS OF COW`S MILK | |
AU3657600A (en) | Biologically active compounds of (ganoderma pfeifferi) dms 13239 | |
WO2005019241A3 (en) | Cationic antimicrobial peptides and compositions thereof | |
AU9157301A (en) | Grain fractionation methods and products | |
AU2119200A (en) | Medicament | |
WO2019175783A8 (en) | Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms | |
WO2002029030A3 (en) | Ethanol production | |
WO2002000687A3 (en) | Antimicrobial peptides and methods of use thereof | |
WO2023004415A3 (en) | Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments | |
Bourgeois et al. | Characterization of AtlL, a bifunctional autolysin of Staphylococcus lugdunensis with N-acetylglucosaminidase and N-acetylmuramoyl-l-alanine amidase activities | |
WO2001084937A8 (en) | Oxidoreductase mediated antimicrobial activity | |
RU2001104332A (en) | BIOLOGICAL PRODUCT FOR PROTECTION OF PLANTS FROM FUNGAL AND BACTERIAL DISEASES | |
ATE299177T1 (en) | LACTIC ACID BACTERIA AND THEIR APPLICATION FOR THE PRODUCTION OF HYPERCHOLESTEROLEMIC ACTIVE PRODUCTS | |
WO2005086669A3 (en) | Hydrogenase deficient bacterial strains | |
AU1539695A (en) | Bacterial strains of genus (bacillus) closely phenotypically related to genus (lactobacillus), culture method and use | |
EP1236402A3 (en) | Compositions containing legume products | |
WO2003044047A3 (en) | Virulence proteins of the genus yersinia and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2382840 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 73324/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000961363 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000961363 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/10-10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000961363 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 73324/00 Country of ref document: AU |